207 related articles for article (PubMed ID: 17460399)
1. Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults.
Margolis DJ; Hoffstad O; Bilker W
Dermatology; 2007; 214(4):289-95. PubMed ID: 17460399
[TBL] [Abstract][Full Text] [Related]
2. Association between exposure to topical tacrolimus or pimecrolimus and cancers.
Hui RL; Lide W; Chan J; Schottinger J; Yoshinaga M; Millares M
Ann Pharmacother; 2009 Dec; 43(12):1956-63. PubMed ID: 19903860
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cancer risk related to atopic dermatitis and use of topical calcineurin inhibitors.
Tennis P; Gelfand JM; Rothman KJ
Br J Dermatol; 2011 Sep; 165(3):465-73. PubMed ID: 21466537
[TBL] [Abstract][Full Text] [Related]
4. Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies.
Thaçi D; Salgo R
Clin Dermatol; 2010; 28(1):52-6. PubMed ID: 20082951
[TBL] [Abstract][Full Text] [Related]
5. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
Naylor M; Elmets C; Jaracz E; Rico JM
J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180
[TBL] [Abstract][Full Text] [Related]
6. [Topical pimecrolimus and tacrolimus and the risk of cancer].
Sánchez-Pérez J
Actas Dermosifiliogr; 2007 Jun; 98(5):312-7. PubMed ID: 17555673
[TBL] [Abstract][Full Text] [Related]
7. [Topical calcineurin inhibitors in atopic eczema -- contra].
Abeck D
Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1615. PubMed ID: 16823714
[No Abstract] [Full Text] [Related]
8. The topical calcineurin inhibitor pimecrolimus in atopic dermatitis: a safety update.
Thaçi D; Salgo R
Acta Dermatovenerol Alp Pannonica Adriat; 2007 Jun; 16(2):58, 60-62. PubMed ID: 17992459
[TBL] [Abstract][Full Text] [Related]
9. Topical treatments with pimecrolimus, tacrolimus and medium- to high-potency corticosteroids, and risk of lymphoma.
Schneeweiss S; Doherty M; Zhu S; Funch D; Schlienger RG; Fernandez-Vidaurre C; Seeger JD
Dermatology; 2009; 219(1):7-21. PubMed ID: 19293564
[TBL] [Abstract][Full Text] [Related]
10. [Topical calcineurin inhibitors in atopic eczema -- pro].
Wollenberg A
Dtsch Med Wochenschr; 2006 Jul; 131(28-29):1614. PubMed ID: 16823713
[No Abstract] [Full Text] [Related]
11. Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.
Munzenberger PJ; Montejo JM
Pharmacotherapy; 2007 Jul; 27(7):1020-8. PubMed ID: 17594208
[TBL] [Abstract][Full Text] [Related]
12. Topical treatment of atopic dermatitis.
Boguniewicz M
Immunol Allergy Clin North Am; 2004 Nov; 24(4):631-44, vi-vii. PubMed ID: 15474863
[TBL] [Abstract][Full Text] [Related]
13. Topical calcineurin inhibitors for the treatment of vulvar dermatoses.
Goldstein AT; Thaçi D; Luger T
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):22-9. PubMed ID: 19631446
[TBL] [Abstract][Full Text] [Related]
14. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force.
Berger TG; Duvic M; Van Voorhees AS; VanBeek MJ; Frieden IJ;
J Am Acad Dermatol; 2006 May; 54(5):818-23. PubMed ID: 16635663
[No Abstract] [Full Text] [Related]
15. Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis.
Ingram JR; Martin JA; Finlay AY
Am J Clin Dermatol; 2009; 10(4):229-37. PubMed ID: 19489656
[TBL] [Abstract][Full Text] [Related]
16. [Calcineurin inhibitors in treatment of atopic dermatitis. Topical corticoids now only in severe outbreaks? ].
MMW Fortschr Med; 2003 Jul; 145(29-30):62. PubMed ID: 12958787
[No Abstract] [Full Text] [Related]
17. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption.
Pariser D
Am J Ther; 2009; 16(3):264-73. PubMed ID: 19262357
[TBL] [Abstract][Full Text] [Related]
18. [Local treatment of atopic dermatitis with calcineurin inhibitors].
Langeland T
Tidsskr Nor Laegeforen; 2006 Jan; 126(3):321-2. PubMed ID: 16440040
[No Abstract] [Full Text] [Related]
19. Off-label topical calcineurin inhibitor use in children.
Manthripragada AD; Pinheiro SP; MaCurdy TE; Saneinejad S; Worrall CM; Kelman JA; Graham DJ
Pediatrics; 2013 Nov; 132(5):e1327-32. PubMed ID: 24127469
[TBL] [Abstract][Full Text] [Related]
20. Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks.
Qureshi AA; Fischer MA
Arch Dermatol; 2006 May; 142(5):633-7. PubMed ID: 16702502
[No Abstract] [Full Text] [Related]
[Next] [New Search]
